TELA Bio, Inc. Annual Operating Income (Loss) in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
TELA Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2024.
  • TELA Bio, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$8.35M, a 32% increase year-over-year.
  • TELA Bio, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$34.1M, a 22.6% increase year-over-year.
  • TELA Bio, Inc. annual Operating Income (Loss) for 2024 was -$34.1M, a 22.6% increase from 2023.
  • TELA Bio, Inc. annual Operating Income (Loss) for 2023 was -$44.1M, a 13% decline from 2022.
  • TELA Bio, Inc. annual Operating Income (Loss) for 2022 was -$39M, a 32.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$34.1M +$9.96M +22.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-21
2023 -$44.1M -$5.07M -13% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-21
2022 -$39M -$9.56M -32.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-21
2021 -$29.5M -$4.18M -16.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-22
2020 -$25.3M -$6.11M -31.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$19.2M -$1.38M -7.76% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-23
2018 -$17.8M -$858K -5.07% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-25
2017 -$16.9M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.